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The	 fibrate	 group	 of	 drugs,	 widely	 used	 to	 treat	 hypertriglyceridemia	usually	also	 increase	 the	cardio	
protective	HdL-	 cholesterol	 levels.	However,	 there	have	
been	a	 few	 reports	describing	a	paradoxical	decrease	 in	
the	serum	HdL-	cholesterol	in	patients	treated	with	fibrates	
alone1-7	or	in	combination	with	statins.8	This	phenomenon	
has	been	 reported	with	bezafibrate,4,6	 ciprofibrate3,5	 and	
more	 recently,	with	 fenofibrate.7	There	are	 also	 reports	
of	 a	 decrease	 in	HdL	 cholesterol	with	 a	 fibratestatin	
combination.8	We	document	here	three	cases	of	paradoxical	
decrease	in	serum	HdL-cholesterol	in	diabetic	patients	on	









Physical	 examination	 revealed	no	 abnormality.	His	
body	mass	 index	was	26.36	kg/m2,	blood	pressure	was	
110/72	mm	Hg	and	his	 renal	 function	was	normal.	He	
had	been	on	 treatment	 for	 hypercholesterolemia	 and	
was	on	Atorvastatin	(10	mg	daily).	On	this	dose,	his	serum	





































A	 49	 year	 old	male,	 a	 non-smoker	 and	 teetotaller	
presented	to	our	centre	with	type	2	diabetes	of	10	years’	
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For	hyperlipidaemia,	he	had	been	on	 treatment	with	
atorvastatin	10	mg	daily.	With	 this	dose,	his	 serum	 lipid	
values	were:	 serum	cholesterol:	202	mg/dl;	 triglycerides	














Fibrates, 	 general ly 	 prescr ibed	 for 	 control 	 of	










it	may	not	be	consistently	 reproducible,	 if	 such	patients	
are	 re-challenged	with	fibrate	 (v)	 there	 is	 an	 increased	
catabolism	and	decreased	synthesis	of	apolipoprotein	A	
containing	lipoprotein	(vi)	it	may	become	evident	as	early	











cases	 reported	here,	 the	statin	was	atorvastatin	and	 the	
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